Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dental Restorations Effect on Oxidative Status of the Gingival Crevicular Fluid

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03522532
Recruitment Status : Completed
First Posted : May 11, 2018
Last Update Posted : May 11, 2018
Sponsor:
Collaborator:
University of Belgrade
Information provided by (Responsible Party):
Ervin Taso, Military Medical Academy, Belgrade, Serbia

Brief Summary:
The goal of the study was to ascertain the influence of dental caries and teeth position as well as the type and amount of the applied dental materials (DMs) on the oxidative stress (OS) status in gingival crevicular fluid (GCF).

Condition or disease Intervention/treatment Phase
Pharmacological Action Procedure: Amalgam placement Procedure: Tetric EvoCeram placement Procedure: Beautifil placement Procedure: Zinc phosphate cement placement Procedure: Zinc polycarboxylate cement placement Procedure: Glass ionomer cement placement Not Applicable

Detailed Description:

Six DMs were tested by investigators, each sealed in one session: amalgam (Amg), zinc phosphate cement (ZnPhC), zinc polycarboxylate cement (ZnPoC), glass ionomer cement (GIC) and composites, Tetric EvoCeram (TEC) and Beautifil (BF).

The study included 88 dental outpatients. Oxidative stress parameters, including malondialdehyde (MDA), glutathione (GSH) and total superoxide dismutase (tSOD) activity were measured in GCF, before (day 0) and after treatment (7th and 30th day).

Antagonistically positioned healthy teeth were used as a control.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 88 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

According to Black's Classification Criteria, patients were classified into four groups (K2 - K5). The number of patients within those groups were as follows: K2 (n=58), K3 (n=10), K4 (n=6) and K5 (n=14).

Six different DMs were used in this study. The type of DM to be used for each patient was determined in relation to the dental lesion degree. DM placement was performed in one session and only one type was used per patient. Accordingly, 6 groups (arms) of dental patients (Amg, ZnPhC, ZnPoC, GIC, TEC and BF) were formed.

Parameters of OS (MDA, GSH and tSOD) were measured in the GCF of the patients both before (day 0) and after treatment (on the 7th and 30th day).

Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Redox Interactions Between Dental Restorations and Gingival Crevicular Fluid
Actual Study Start Date : October 2016
Actual Primary Completion Date : September 2017
Actual Study Completion Date : November 2017

Arm Intervention/treatment
Experimental: Amalgam (Amg)
Amalgam was sealed in 8-K2 patients and 6-K2 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Procedure: Amalgam placement
Before the Amg was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment.

Experimental: Tetric EvoCeram (TEC)
Tetric EvoCeram was sealed in 12-K2 patients and 5-K5 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Procedure: Tetric EvoCeram placement
Before the TEC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment.

Experimental: Beautifil (BF)
Beautifil was sealed in 15-K2 patients. Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.
Procedure: Beautifil placement
Before the BF was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment.

Experimental: Zinc phosphate cement (ZPhC)

Zinc phosphate cement was sealed in 7-K2 patients, 4-K3 patients, 1-K4 patients and 2-K5 patients.

Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.

Procedure: Zinc phosphate cement placement
Before the ZPhC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment.

Experimental: Zinc polycarboxylate cement (ZPoC)

Zinc polycarboxylate cement was sealed in 5-K2 patients, 4-K3 patients and 5-K4 patients.

Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.

Procedure: Zinc polycarboxylate cement placement
Before the ZPoC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment.

Experimental: Glass ionomer cement (GIC)

Glass ionomer cement was sealed in 11-K2 patients, 2-K3 patients and 1-K5 patients.

Oxidative stress parameters (MDA, GSH, tSOD) were measured in GCF prior to treatment and on the 7th and 30th day after treatment.

Procedure: Glass ionomer cement placement
Before the GIC was sealed GCF was taken, and then taken again on the 7th and 30th days after the applied treatment.




Primary Outcome Measures :
  1. Changes in the levels of MDA in dental patients GCF after the applied treatments [ Time Frame: 0th, 7th and 30th days. ]
    The concentration of MDA in GCF was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.


Secondary Outcome Measures :
  1. Changes in the levels of GSH in dental patients GCF after the applied treatments [ Time Frame: 0th, 7th and 30th days. ]
    Concentration of GSH in GCF was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.


Other Outcome Measures:
  1. Changes in tSOD activity in dental patients GCF after the applied treatments [ Time Frame: 0th, 7th and 30th days. ]
    Activity of tSOD was measured before (0 day) and twice after the applied treatments (7th and 30th days). GCF was taken via the intracervical absorption technique. Control GCF (from mirror-positioned health teeth) was taken once before the treatment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Criteria related to the condition of teeth:

  • Presence of proximal caries on anterior and posterior teeth
  • Existence of the antagonistic tooth ("mirror"-positioned healthy tooth) to be used as control
  • An absence of fresh post-extraction or traumatic wounds in the restoration area or in the area of restored surfaces
  • An absence of infection in the area of restored surfaces

Other influencing criteria:

  • Absence of bone-associated diseases or treatments
  • Satisfactory oral hygiene
  • Patients exhibiting good compliance

Exclusion Criteria:

Criteria related to the condition of teeth:

  • Endodontic and/or periodontal infections in the area of the cervical filling
  • Presence of periodontopathy
  • Prominent periodontal pockets
  • Subgingival carries
  • Prominent fillings outside the cavity

Other influencing criteria:

  • Patients on radiation or immunosuppressive therapy
  • Presence of bone-associated diseases and malignant diseases
  • Patients using drugs/alcohol/cigarettes (> 20 cigarettes per day)
  • Bad oral hygiene
  • Patients exhibiting poor compliance

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03522532


Locations
Layout table for location information
Serbia
Military Medical Academy
Belgrade, Serbia, 11000
Sponsors and Collaborators
Ervin Taso
University of Belgrade
Investigators
Layout table for investigator information
Principal Investigator: Mirjana M Djukic, PhD, Pharm. University of Belgrade
Study Director: Danilo V Vojvodic Military Medical Academy, Belgrade
Publications:

Layout table for additonal information
Responsible Party: Ervin Taso, Principal Investigator, Military Medical Academy, Belgrade, Serbia
ClinicalTrials.gov Identifier: NCT03522532    
Other Study ID Numbers: VMA/10-12/A.1
First Posted: May 11, 2018    Key Record Dates
Last Update Posted: May 11, 2018
Last Verified: April 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Keywords provided by Ervin Taso, Military Medical Academy, Belgrade, Serbia:
dental restorations
gingival crevicular fluid
glutathione
lipid peroxidation
superoxide dismutase
Additional relevant MeSH terms:
Layout table for MeSH terms
Zinc
Trace Elements
Micronutrients
Physiological Effects of Drugs